An overview on the impact of viral pathogens on Alzheimer's disease

被引:0
|
作者
Amelimojarad, Melika [1 ]
Amelimojarad, Mandana [1 ]
Cui, Xiaonan [1 ]
机构
[1] Dalian Med Univ, Affiliate Hosp 1, Dept Oncol, Zhongshan Rd, Dalian 116011, Liaoning, Peoples R China
关键词
Alzheimer's disease; BBB; SARS-CoV-2; HSV; Viral pathogens; BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; MOUSE MODEL; IN-VITRO; MECHANISM; PROTEIN; NEUROINFLAMMATION; EXPRESSION; INFECTION; MICROGLIA;
D O I
10.1016/j.arr.2024.102615
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is the most common type of dementia which affects over than 60 million cases worldwide with higher incidence in low and middle-income countries by 2030. Based on the multifactorial nature of AD different risk factors are linked to the condition considering the brain's beta-amyloid plaques (A beta) and neurofibrillary tangles (NFTs) as its primary hallmarks. Lately, viral photogenes specially after recent SARS-CoV2 pandemic has gained a lot of attention in promoting the neurodegenerative disorder such as AD based on their capacity to increase the permeability of the blood-brain barrier, dysregulation of immune responses, and the impact on A beta processing and phosphorylation of tau proteins. Therefore, in this review, we summarized the important association of viral pathogens and their mechanism by which they contribute with AD formation and development. An overview of the roles of viral pathogens in AD: According to this figure, viruses can infect neurons directly by modulating the BBB, transferring from endothelial cells to glial cells and then to neurons, increasing the A beta deposition, and affecting the tau protein phosphorylation or indirectly through the virus's entrance and pathogenicity that can be accelerated by genetic and epigenetic factors, as well as chronic neuroinflammation caused by activated microglia and astrocytes.
引用
收藏
页数:8
相关论文
共 50 条
  • [42] Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews
    Reza Majidazar
    Erfan Rezazadeh-Gavgani
    Saeed Sadigh-Eteghad
    Amirreza Naseri
    European Journal of Clinical Pharmacology, 2022, 78 : 1567 - 1587
  • [43] Factors Associated with Alzheimer's Disease: An Overview of Reviews
    Rochoy, M.
    Rivas, V.
    Chazard, E.
    Decarpentry, E.
    Saudemont, G.
    Hazard, P. -A.
    Puisieux, F.
    Gautier, S.
    Bordet, R.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2019, 6 (02): : 121 - 134
  • [44] Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview
    Bilal, Muhammad
    Barani, Mahmood
    Sabir, Fakhara
    Rahdar, Abbas
    Kyzas, George Z.
    NANOIMPACT, 2020, 20
  • [45] Alzheimer's Disease: An Updated Overview of Its Genetics
    Andrade-Guerrero, Jesus
    Santiago-Balmaseda, Alberto
    Jeronimo-Aguilar, Paola
    Vargas-Rodriguez, Isaac
    Ruth Cadena-Suarez, Ana
    Sanchez-Garibay, Carlos
    Pozo-Molina, Glustein
    Fabiola Mendez-Catala, Claudia
    Cardenas-Aguayo, Maria-del-Carmen
    Diaz-Cintra, Sofia
    Pacheco-Herrero, Mar
    Luna-Munoz, Jose
    Soto-Rojas, Luis O.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [46] An overview of the social and behavioral consequences of Alzheimer's disease
    Pearlin, LI
    Harrington, C
    Lawton, MP
    Montgomery, RJV
    Zarit, SH
    AGING & MENTAL HEALTH, 2001, 5 (02) : S3 - S6
  • [47] Factors Associated with Alzheimer’s Disease: An Overview of Reviews
    Michaël Rochoy
    V. Rivas
    E. Chazard
    E. Decarpentry
    G. Saudemont
    P.-A. Hazard
    F. Puisieux
    S. Gautier
    R. Bordet
    The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 121 - 134
  • [48] Personalizing the Care and Treatment of Alzheimer's Disease: An Overview
    Strac, Dubravka Svob
    Konjevod, Marcela
    Sagud, Marina
    Perkovic, Matea Nikolac
    Erjavec, Gordana Nedic
    Vuic, Barbara
    Simic, Goran
    Vukic, Vana
    Mimica, Ninoslav
    Pivac, Nela
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 631 - 653
  • [49] Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease
    Rajesh Singh Yadav
    Neeraj Kumar Tiwari
    Molecular Neurobiology, 2014, 50 : 168 - 176
  • [50] Angiotensins and Alzheimer's disease: a bench to bedside overview
    Patrick G Kehoe
    Alzheimers Res Ther, 1